Skip to content

H.R. 5027 · 118th Congress (2023–2025)

Chronic Kidney Disease Improvement in Research and Treatment Act of 2023

To improve the understanding of, and promote access to treatment for, chronic kidney disease, and for other purposes.

CRS summary not yet available.

Expired in House committee

Derived from the legislative history, not an official disposition.

Latest actionReferred to Health

This bill’s path

This is H.R. 5027’s recorded path, not a universal congressional workflow.

How bills become lawAll actions
  1. Introduced

  2. Passed House

  3. Passed Senate

  4. Sent to President

  5. Signed into law

  6. Expired

Sponsor
Rep. Carol D. Miller (R-WV-1)
Cosponsors
13 cosponsors

1 original · 12 later

2 R · 11 D

  1. Rep. Terri A. Sewell (D-AL-7)· Original · Jul 27, 2023
  2. Rep. Susan Wild (D-PA-7)· Later · Sep 20, 2023
  3. Rep. Jerrold Nadler (D-NY-12)· Later · Oct 19, 2023
  4. Rep. Yadira Caraveo (D-CO-8)· Later · Dec 4, 2023
  5. Rep. Yvette D. Clarke (D-NY-9)· Later · Dec 6, 2023
  6. Rep. Vern Buchanan (R-FL-16)· Later · Dec 19, 2023
  7. Rep. Michelle Steel (R-CA-45)· Later · Feb 29, 2024
  8. Del. Eleanor Holmes Norton (D-DC)· Later · May 7, 2024
  9. Rep. Steve Cohen (D-TN-9)· Later · May 24, 2024
  10. Rep. Frank J. Mrvan (D-IN-1)· Later · May 24, 2024
  11. Rep. Raja Krishnamoorthi (D-IL-8)· Later · Jun 13, 2024
  12. Rep. Alma S. Adams (D-NC-12)· Later · Aug 6, 2024
  13. Rep. Joe Neguse (D-CO-2)· Later · Dec 17, 2024
Policy area
Health
Subjects
  • Advanced technology and technological innovations
  • Congressional oversight
  • Digestive and metabolic diseases
  • Drug therapy
  • Government studies and investigations
  • Health care coverage and access
  • Health personnel
  • Health promotion and preventive care
  • 8 more
    • Health technology, devices, supplies
    • Higher education
    • Medical research
    • Medical tests and diagnostic methods
    • Medicare
    • National and community service
    • Prescription drugs
    • Student aid and college costs

On this page

Timeline

i

In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.

  1. Introduced in House

    Document: Introduced in House

    Sources
  2. Latest
    ▸ 3 committee actions · Jul 27, 2023 – Dec 17, 2024
    1. Referred to committee

      Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

      Sources
    2. Referred to Health

      Referred to the Subcommittee on Health.

      Sources
    3. Referred to Health

      Referred to the Subcommittee on Health.

      Sources
  3. Expired

    Introduced → Referred to House Health → No further action before the 118th Congress ended.

Committees

  1. HouseEnergy and CommerceReferred Jul 27, 2023
  2. HouseHealthReferred Jul 28, 2023
  3. HouseWays and MeansReferred Jul 27, 2023
  4. HouseHealthReferred Dec 17, 2024

Text & titles

i

Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.

Text versions
VersionDateLinks
Introduced in House
Titles (2)
  1. Chronic Kidney Disease Improvement in Research and Treatment Act of 2023

    Display title, Short title · Introduced in House

  2. To improve the understanding of, and promote access to treatment for, chronic kidney disease, and for other purposes.

    Official title · Introduced in House